Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration.
D000328:Adult; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D010956:Plasmapheresis; D011183:Postoperative Complications; D012189:Retrospective Studies
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D015774:Ganciclovir